Castle Biosciences Ownership | Who Owns Castle Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Castle Biosciences Ownership Summary


Castle Biosciences is owned by 94.55% institutional investors, 3.37% insiders, and 2.09% retail investors. Blackrock is the largest institutional shareholder, holding 11.08% of CSTL shares. Bellevue Healthcare Ord is the top mutual fund, with 4.32% of its assets in Castle Biosciences shares.

CSTL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCastle Biosciences94.55%3.37%2.09%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryDiagnostics & Research Stocks49.06%8.59%42.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.04M11.08%$66.29M
Blackrock funding, inc. /de2.92M10.49%$77.85M
Vanguard group1.83M6.58%$48.84M
Wasatch advisors lp1.80M6.45%$47.87M
Principal financial group1.44M5.16%$38.26M
Dimensional fund advisors lp999.47K3.59%$26.64M
Ubs group812.60K2.92%$21.66M
Portolan capital management776.58K2.79%$20.70M
Bellevue group745.98K2.68%$19.88M
Wellington management group llp722.12K2.59%$19.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Abg innovation capital partners iii gp36.75K90.45%$979.31K
Birchview capital, lp78.00K1.69%$2.08M
Portolan capital management776.58K1.39%$20.70M
Yu fan22.50K1.13%$599.71K
Parkman healthcare partners304.63K1.08%$8.12M
Perkins capital management34.16K0.81%$910.50K
Intrinsic edge capital management232.71K0.75%$6.20M
Hussman strategic advisors73.50K0.58%$1.96M
Next century growth investors235.21K0.47%$6.27M
Soleus capital management252.92K0.42%$6.74M

Top Buyers

HolderShares% AssetsChange
Ubs group812.60K0.00%758.47K
Wellington management group llp722.12K0.00%722.12K
Blackrock3.04M0.00%449.29K
Millennium management548.81K0.01%408.27K
Allianz asset management gmbh322.37K0.01%251.82K

Top Sellers

HolderShares% AssetsChange
Bellevue group745.98K0.38%-516.05K
Portolan capital management776.58K1.39%-479.05K
Soleus capital management252.92K0.42%-409.42K
Morgan stanley249.38K0.00%-401.33K
Braidwell lp---331.99K

New Positions

HolderShares% AssetsChangeValue
Wellington management group llp722.12K0.00%722.12K$19.24M
Bnp paribas arbitrage, snc249.13K0.00%249.13K$6.64M
D. e. shaw90.56K0.00%90.56K$2.41M
Hussman strategic advisors73.50K0.58%73.50K$1.96M
Healthcare of ontario pension plan trust fund35.80K0.00%35.80K$954.07K

Sold Out

HolderChange
National bank of canada /fi/-1.00
Colonial trust advisors-6.00
Fairman group-13.00
Capital performance advisors llp-33.00
Pnc financial services group-38.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242023.59%26,322,0332.20%941.10%106-11.67%6538.30%
Sep 30, 202419518.90%25,754,3952.29%921.12%11938.37%48-4.00%
Jun 30, 20241637.24%25,178,6030.98%911.08%8518.06%50-7.41%
Mar 31, 2024152-0.65%24,935,0634.70%921.17%72-21.74%5425.58%
Dec 31, 202315312.50%23,814,7983.24%881.19%9226.03%437.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Bellevue Healthcare Ord1.20M4.32%1.20M
Vanguard US Total Market Shares ETF829.40K2.96%-
Vanguard Total Stock Mkt Idx Inv830.64K2.91%-
Strategic Advisers U.S. Total Stock{mg}693.06K2.47%-
iShares Russell 2000 ETF691.25K2.42%-6.00K
Wasatch Small Cap Growth Investor675.19K2.41%-14.34K
Strategic Advisers Small-Mid Cap665.91K2.40%62.85K
Principal SmallCap R5624.80K2.19%-8.40K
Principal U.S. Small Cap Equity560.90K2.00%-3.60K
Strategic Advisers U.S. Total Stock442.80K1.55%66.23K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 08, 2025MAETZOLD DEREK J Pres. & Chief Exec. OfficerSell$6.97K
Apr 09, 2025MAETZOLD DEREK J Pres. & Chief Exec. OfficerSell$33.75K
Apr 08, 2025MAETZOLD DEREK J Pres. & Chief Exec. OfficerSell$4.27K
Apr 09, 2025MAETZOLD DEREK J Pres. & Chief Exec. OfficerSell$20.68K
Apr 08, 2025MAETZOLD DEREK J Pres. & Chief Exec. OfficerSell$5.99K

Insider Transactions Trends


DateBuySell
2025 Q2-10
2025 Q1-61
2024 Q4-64
2024 Q3-55
2024 Q2-51

CSTL Ownership FAQ


Who Owns Castle Biosciences?

Castle Biosciences shareholders are primarily institutional investors at 94.55%, followed by 3.37% insiders and 2.08% retail investors. The average institutional ownership in Castle Biosciences's industry, Diagnostics & Research Stocks, is 49.06%, which Castle Biosciences exceeds.

Who owns the most shares of Castle Biosciences?

Castle Biosciences’s largest shareholders are Blackrock (3.04M shares, 11.08%), Blackrock funding, inc. /de (2.92M shares, 10.49%), and Vanguard group (1.83M shares, 6.58%). Together, they hold 28.15% of Castle Biosciences’s total shares outstanding.

Does Blackrock own Castle Biosciences?

Yes, BlackRock owns 11.08% of Castle Biosciences, totaling 3.04M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 66.29M$. In the last quarter, BlackRock increased its holdings by 449.29K shares, a 17.31% change.

Who is Castle Biosciences’s biggest shareholder by percentage of total assets invested?

Abg innovation capital partners iii gp is Castle Biosciences’s biggest shareholder by percentage of total assets invested, with 90.45% of its assets in 36.75K Castle Biosciences shares, valued at 979.31K$.

Who is the top mutual fund holder of Castle Biosciences shares?

Bellevue Healthcare Ord is the top mutual fund holder of Castle Biosciences shares, with 4.32% of its total shares outstanding invested in 1.2M Castle Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools